MAXY

Maxygen Reports Fourth Quarter and Year End 2012 Financial Results

[Business Wire] – Maxygen, Inc. , a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2012. moreView todays social media effects on MAXYView the latest stocks trending across Twitter. Click to view dashboardSee who Maxygen is hiring next, click here to view […]

Maxygen Announces Tax Treatment of 2012 Cash Distribution

[at noodls] – January 29, 2013 SAN MATEO, Calif., January 29, 2013 ─ Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company, today announced that its distribution of cash in September 2012 primarily will be classified … moreView todays social media effects on MAXYView the latest stocks trending across Twitter. Click to view dashboardSee who Maxygen is hiring next, click here to […]

Maxygen Announces Tax Treatment of 2012 Cash Distribution

[Business Wire] – Maxygen, Inc. , a biotechnology company, today announced that its distribution of cash in September 2012 primarily will be classified as a return of capital to its stockholders for U.S. moreView todays social media effects on MAXYView the latest stocks trending across Twitter. Click to view dashboardSee who Maxygen is hiring next, click here to view […]

Maxygen Announces Third Quarter 2012 Financial Results

[at noodls] – November 6, 2012 SAN MATEO, Calif., November 6, 2012 ─ Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company, today announced financial and business results for the quarter ended September 30, 2012. Third … moreView todays social media effects on MAXYView the latest stocks trending across Twitter. Click to view dashboard […]